SE0401567D0 - Concentration of beta-glucans - Google Patents

Concentration of beta-glucans

Info

Publication number
SE0401567D0
SE0401567D0 SE0401567A SE0401567A SE0401567D0 SE 0401567 D0 SE0401567 D0 SE 0401567D0 SE 0401567 A SE0401567 A SE 0401567A SE 0401567 A SE0401567 A SE 0401567A SE 0401567 D0 SE0401567 D0 SE 0401567D0
Authority
SE
Sweden
Prior art keywords
beta glucan
beta
concentration
glucans
containing product
Prior art date
Application number
SE0401567A
Other languages
English (en)
Inventor
John Mark Lawther
Sten Kvist
Original Assignee
Biovelop Internat Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovelop Internat Bv filed Critical Biovelop Internat Bv
Priority to SE0401567A priority Critical patent/SE0401567D0/sv
Publication of SE0401567D0 publication Critical patent/SE0401567D0/sv
Priority to PCT/SE2005/000883 priority patent/WO2005122785A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/104Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A23L7/107Addition or treatment with enzymes not combined with fermentation with microorganisms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
SE0401567A 2004-06-17 2004-06-17 Concentration of beta-glucans SE0401567D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0401567A SE0401567D0 (sv) 2004-06-17 2004-06-17 Concentration of beta-glucans
PCT/SE2005/000883 WO2005122785A1 (en) 2004-06-17 2005-06-13 Concentration of beta-glucans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401567A SE0401567D0 (sv) 2004-06-17 2004-06-17 Concentration of beta-glucans

Publications (1)

Publication Number Publication Date
SE0401567D0 true SE0401567D0 (sv) 2004-06-17

Family

ID=32906806

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401567A SE0401567D0 (sv) 2004-06-17 2004-06-17 Concentration of beta-glucans

Country Status (2)

Country Link
SE (1) SE0401567D0 (sv)
WO (1) WO2005122785A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI120131B (sv) 2007-02-08 2009-07-15 Valtion Teknillinen Förfarande för fraktionering av havre, så erhållna produkter och användning
WO2011061144A2 (en) 2009-11-20 2011-05-26 Basf Se The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen
ES2391192B2 (es) 2011-04-28 2013-06-18 Universidad De Murcia Procedimiento y sistema para la medida de la difusión intraocular.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960697A (en) * 1989-01-06 1990-10-02 The Standard Oil Company Recovery of polysaccharides by employing a divalent cation with a water miscible organic solvent
FI94015C (sv) * 1993-06-04 1995-07-10 Exavena Oy Förfarande för anrikning av löslig näringsfiber
US5518710A (en) * 1994-01-11 1996-05-21 University Of Saskatchewan Methods for extracting cereal β-glucans
DE69726874T2 (de) * 1996-09-25 2004-10-14 Gracelinc Ltd. Beta-glukan produkte und deren extraktionsverfahren aus cerealien
US6113908A (en) * 1999-03-22 2000-09-05 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Methods for processing oat groats and products thereof
DE60133632T2 (de) * 2000-02-07 2009-05-28 Granate Seed Ltd. Verfahren zur extraktion von -g(b)-glucan aus getreide und daraus hergestellte produkte
DE60135658D1 (de) * 2000-07-03 2008-10-16 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
WO2005122785A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
WO2007089851A3 (en) Compositions and methods for treating collagen-mediated diseases
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
DE60230160D1 (de) 2-arylaminopyrimidine zur behandlung von mit gsk3 in zusammenhang stehenden erkrankungen
WO2005074607A3 (en) Method of treating hemolytic disease
WO2006099941A8 (de) Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20053179L (no) Aldonsyreestere, fremgangsmater for fremstilling derav og fremgangsmater for fremstilling av farmasoytisk aktive ingredienser som er bundet til polysakkarider eller polysakkarid-derivater pa frie aminogrupper.
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
WO2007010281A3 (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
BRPI0408631A (pt) composição protéica em pó
BRPI0406903A (pt) Produtos de 5'-ribonucleotìdeos
CY1110896T1 (el) Μια νεα αντιμυκητιακη συνθεση
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
WO2006078648A3 (en) Rhinovirus vaccines
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE372776T1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
NO20070351L (no) Materialer og fremgangsmater for forbedring av skalldyrhelse, -immunitet og -vekst
SE0401567D0 (sv) Concentration of beta-glucans
DE60104687D1 (de) Mikrofiltration unter verwendung von aktivkohle
ITMI20021801A1 (it) Prodotti di pomodoro.
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
ATE424833T1 (de) Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure
BR0308736A (pt) Células de pulmão de rato cotton para cultura de vìrus
ATE279918T1 (de) Verwendung von aloe-emodin zur behandlung von neuroektodermalen tumoren
ATE496047T1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien